Emily Field

Stock Analyst at Barclays

(2.51)

# 2,106

Out of 4,820 analysts

6

Total ratings

66.67%

Success rate

11.2%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - General

Stocks Rated by Emily Field

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	GLPG Galapagos NV	Downgrades: Underweight	n/a	$26.49	-	1	Jan 23, 2025
	GSK GSK plc	Upgrades: Equal-Weight	n/a	$37.50	-	4	Nov 5, 2021
	ARGX argenx SE	Upgrades: Overweight	n/a	$600.51	-	1	Oct 19, 2021

Galapagos NV

Jan 23, 2025

Downgrades: Underweight

Price Target: n/a

Current: $26.49

Upside: -

GSK plc

Nov 5, 2021

Upgrades: Equal-Weight

Price Target: n/a

Current: $37.50

Upside: -

argenx SE

Oct 19, 2021

Upgrades: Overweight

Price Target: n/a

Current: $600.51

Upside: -